Skip to main content
Addgene

MTA Ancillary Agreement: Sangamo Zinc-Finger Agreement

Ancillary Agreement for Zinc-Finger Plasmids

Please consult the accompanying implementing letter for definitions of
ORIGINAL MATERIAL, RECIPIENT, and RECIPIENT SCIENTIST regarding this
transfer of the ORIGINAL MATERIAL.

By agreeing to this Ancillary Agreement, the RECIPIENT agrees to the
following:

1) The ORIGINAL MATERIAL and any derived or modified product
("MODIFICATION") , or the use or manufacture of the ORIGINAL
MATERIAL or MODIFICATION may be covered by third party intellectual
property, including without limitation patents and/or patent
applications controlled and/or filed by Sangamo BioSciences, Inc.
(U.S. Patent Nos. 6,534,261, 6,607,882, 6,746,838, 6,794,136,
6,824,978, 6,866,997, 6,933,113, 6,979,539, 7,013,219, 7,030,215,
Australian Patent Nos. 732017, 745844, European Patent Nos.
1,061,805, 1,364,020, Great Britain Patent Nos 2,348,424, U.S.
Patent Application Publication Nos. 2003/0232410, 2005/0064474,
2006/0188987, and International Patent Application Publication No.
WO 01/53480), and that

2) No licenses to any such intellectual property are granted
hereunder. As a result, RECIPIENT's use of the ORIGINAL MATERIAL or
MODIFICATIONS may require licenses from one or more third parties,
and RECIPIENT accepts sole responsibility for obtaining any such
licenses. The distribution of the ORIGINAL MATERIAL by Addgene is
not meant to carry with it, and does not grant any license, express
or implied, under any patent.

To learn how to obtain a license regarding the use of these plasmids,
please visit www.addgene.org/sangamo